SEMA3D and neoplasm: To further explore the potential mechanisms of Sema3D inhibiting tumor progression, based on the Sema3D expression level (<25% low group and >75% high group), we carried out a differential expression analysis of the RNAseq data in ccRCC from TCGA database.